The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria Parasite

Author:

Ellis Katherine M.1,Lucantoni Leonardo2,Chavchich Marina3ORCID,Abraham Matthew4,De Paoli Amanda1,Luth Madeline R.4,Zeeman Anne-Marie5,Delves Michael J.6,Terán Fernando Sánchez-Román6,Straschil Ursula6,Baum Jake6ORCID,Kocken Clemens H. M.5,Ralph Stuart A.7ORCID,Winzeler Elizabeth A.4,Avery Vicky M.2,Edstein Michael D.3,Baell Jonathan B.8,Creek Darren J.1ORCID

Affiliation:

1. Drug Delivery Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia

2. Discovery Biology, Griffith University, Nathan, QLD, Australia

3. The Department of Drug Evaluation, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, QLD, Australia

4. School of Medicine, University of California, San Diego, La Jolla, California, USA

5. Department of Parasitology, Biomedical Primate Research Centre, Rijswijk, Netherlands

6. Department of Life Sciences, Imperial College London, South Kensington, London, United Kingdom

7. Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Parkville, VIC, Australia

8. Medicinal Chemistry, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, VIC, Australia

Abstract

Novel bis-1,2,4-triazine compounds with potent in vitro activity against Plasmodium falciparum parasites were recently identified. The bis-1,2,4-triazines represent a unique antimalarial pharmacophore and are proposed to act by a novel but as-yet-unknown mechanism of action.

Funder

Department of Health, Australian Government | National Health and Medical Research Council

Medicines for Malaria Venture

Wellcome

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference45 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3